Literature DB >> 8612487

Cloning of rat 17 beta-hydroxysteroid dehydrogenase type 2 and characterization of tissue distribution and catalytic activity of rat type 1 and type 2 enzymes.

L A Akinola1, M Poutanen, R Vihko.   

Abstract

17 beta-Hydroxysteroid dehydrogenases (17HSDs) are enzymes catalyzing the conversion between 17 beta-hydroxy- and 17-ketosteroids. Both estrogens and androgens possess their highest activity in the 17 beta-hydroxy form, and the enzymes, therefore, regulate the biological activity of sex hormones. In this study, we have characterized the complementary DNA (cDNA) for rat 17HSD type 2. The cDNA encodes a protein with a predicted mol wt of 42,010 Da. The protein has 77% similarity and 62% identity with the human 17HSD type 2 enzyme. Furthermore, the hydropathicity profiles of the enzymes are very similar. The two isozymes contain a putative transmembrane region close to the N-terminus. However, the rat isozyme lacks the two lysine-rich amino acid cluster present at the N- and C-terminals of human 17HSD type 2. The tissue distribution of the rat 17HSD type 1 and type 2 enzymes is very similar to that of the human enzymes. The highest expression of 17HSD type 2 was detected in the placenta. In addition, a 1.5-kilobase messenger RNA for the enzyme was detected in the small intestine, liver, and kidney of both sexes. The two messenger RNAs for rat 17HSD type 1 (1.4 and 1.7 kilobases) were highly expressed only in the ovary, and at very low concentrations in the kidney of both sexes. Transiently expressed rat 17HSD type 2 showed oxidative activity almost exclusively in cultured human embryonic kidney 293 cells, converting estradiol into estrone and testosterone into androstenedione, whereas the opposite was observed for the rat type 1 enzyme. The data suggest that similarly to the corresponding human isoforms, rat 17HSD type 2 is mostly involved in the oxidation of 17 beta-hydroxysteroids into their relatively inactive keto derivative in peripheral tissues, whereas rat 17HSD type 1 is mainly involved in the glandular biosynthesis of estradiol.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612487     DOI: 10.1210/endo.137.5.8612487

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  Estrogen metabolism as a regulator of estrogen action in the mammary gland.

Authors:  M Miettinen; V Isomaa; H Peltoketo; D Ghosh; P Vihko
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

2.  Cloning of mouse 17beta-hydroxysteroid dehydrogenase type 2, and analysing expression of the mRNAs for types 1, 2, 3, 4 and 5 in mouse embryos and adult tissues.

Authors:  M V Mustonen; M H Poutanen; V V Isomaa; P T Vihko; R K Vihko
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  5alpha-reductase in human embryonic kidney cell line HEK293: evidence for type II enzyme expression and activity.

Authors:  Baerbel U Panter; Joachim Jose; Rolf W Hartmann
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Gestational protein restriction reduces expression of Hsd17b2 in rat placental labyrinth.

Authors:  Haijun Gao; Uma Yallampalli; Chandra Yallampalli
Journal:  Biol Reprod       Date:  2012-09-21       Impact factor: 4.285

5.  A computational model to predict rat ovarian steroid secretion from in vitro experiments with endocrine disruptors.

Authors:  Nadia Quignot; Frédéric Y Bois
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

6.  Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene.

Authors:  Jeffrey F Waring; Roger G Ulrich; Nick Flint; David Morfitt; Arno Kalkuhl; Frank Staedtler; Michael Lawton; Johanna M Beekman; Laura Suter
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.